The RUNX1 Research Program and Alex’s Lemonade Stand Foundation support early-career scientists developing approaches to prevent blood cancer in people with RUNX1 familial platelet disorder (RUNX1-FPD). This three-year grant funds basic and translational research aimed at stopping progression from a premalignant state to hematologic malignancy.
Eligibility Criteria
- Applicants must hold an MD, PhD, MD/PhD, or equivalent degree.
- Must be within five years of their first Assistant Professor or equivalent tenure-track appointment. Associate and Full Professors arineligible; Instructor-level applicants require mentor support.
- Nonprofit institutions worldwide are eligible, with no U.S. citizenship requirement.
- At least 75% of the applicant’s time must be protected for research overall.
- Applicants need relevant expertise in hematopoiesis and/or immunology, with proposals focused on preventing malignant transformation in RUNX1-FPD.
Funding Details
- Up to $180,000 over three years, with a maximum of $60,000 annually.
- Direct costs only; indirect costs are not permitted.
- Continued support depends on satisfactory progress and appropriate expenditure.
Deadline
- December 17, 2026, at 8:00 p.m. Eastern Time.
- Award notifications are expected in March 2027, with funding projected to begin in April 2027.
Further Information
- Official guidelines
- Application information
- Submit through ProposalCentral.
- Eligibility and research questions: kericson@runx1-fpd.org.